Intermittent androgen suppression for rising PSA level after radiotherapy.

Crook, J; O'Callaghan, C; Duncan, G; Dearnaley, D; Higano, C; Horwitz, E; Frymire, E; Malone, S; Chin, J; Nabid, A; Warde, P; Corbett, T; Angyalfi, S; Goldenberg, S; Gospodarowicz, M; Saad, F; Logue, John P; Hall, E; Schellhammer, P; Ding, K; Klotz, L

Affiliation

British Columbia Cancer Agency, Cancer Centre for the Southern Interior, 399 Royal Ave., Kelowna, BC V1Y 5L3, Canada.

Issue Date

2012-09-06

Metadata

Show full item record

Abstract

Intermittent androgen deprivation for prostate-specific antigen (PSA) elevation after radiotherapy may improve quality of life and delay hormone resistance. We assessed overall survival with intermittent versus continuous androgen deprivation in a noninferiority randomized trial.

Citation

Intermittent androgen suppression for rising PSA level after radiotherapy. 2012, 367 (10):895-903 N. Engl J Med

Journal

The New England Journal of Medicine

URI

http://hdl.handle.net/10541/259245

DOI

10.1056/NEJMoa1201546

PubMed ID

22931259

Type

Article

Language

ISSN

1533-4406

Collections

All Christie Publications